Avi On

1.2k total citations · 1 hit paper
26 papers, 776 citations indexed

About

Avi On is a scholar working on Surgery, Epidemiology and Small Animals. According to data from OpenAlex, Avi On has authored 26 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 9 papers in Epidemiology and 8 papers in Small Animals. Recurrent topics in Avi On's work include Helicobacter pylori-related gastroenterology studies (10 papers), Inflammatory Bowel Disease (8 papers) and Microscopic Colitis (8 papers). Avi On is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (10 papers), Inflammatory Bowel Disease (8 papers) and Microscopic Colitis (8 papers). Avi On collaborates with scholars based in Israel, Netherlands and Canada. Avi On's co-authors include Ron Shaoul, Arie Levine, Michal Kori, Sarit Peleg, Shlomi Cohen, Hussein Shamaly, Johan Van Limbergen, L Abramas, Rotem Sigall Boneh and Amit Assa and has published in prestigious journals such as Gastroenterology, American Journal of Tropical Medicine and Hygiene and Clinical Gastroenterology and Hepatology.

In The Last Decade

Avi On

24 papers receiving 766 citations

Hit Papers

Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutri... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avi On Israel 12 483 373 316 127 121 26 776
Anita Kondrashova Finland 11 402 0.8× 255 0.7× 141 0.4× 88 0.7× 167 1.4× 16 745
Trond Rasmussen Norway 16 318 0.7× 199 0.5× 158 0.5× 39 0.3× 120 1.0× 23 629
V. Varea Spain 16 309 0.6× 359 1.0× 435 1.4× 219 1.7× 605 5.0× 37 1.1k
Lena Grahnquist Sweden 13 195 0.4× 220 0.6× 197 0.6× 50 0.4× 153 1.3× 29 570
V. M. Duncombe Australia 17 70 0.1× 259 0.7× 112 0.4× 80 0.6× 288 2.4× 38 691
Kinga Kowalska‐Duplaga Poland 16 297 0.6× 165 0.4× 188 0.6× 329 2.6× 91 0.8× 43 736
Fatemeh Farahmand Iran 14 57 0.1× 343 0.9× 76 0.2× 37 0.3× 185 1.5× 74 640
Cecilia Benoni Sweden 17 628 1.3× 245 0.7× 668 2.1× 91 0.7× 158 1.3× 28 973
Michael Cosgrove United Kingdom 11 149 0.3× 112 0.3× 148 0.5× 51 0.4× 36 0.3× 31 558
Kaija-Leena Kolho Finland 10 317 0.7× 138 0.4× 287 0.9× 426 3.4× 109 0.9× 15 886

Countries citing papers authored by Avi On

Since Specialization
Citations

This map shows the geographic impact of Avi On's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi On with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi On more than expected).

Fields of papers citing papers by Avi On

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avi On. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi On. The network helps show where Avi On may publish in the future.

Co-authorship network of co-authors of Avi On

This figure shows the co-authorship network connecting the top 25 collaborators of Avi On. A scholar is included among the top collaborators of Avi On based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avi On. Avi On is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azrad, Maya, et al.. (2022). Antibiotic resistance patterns of Helicobacter pylori in North Israel – A six‐year study. Helicobacter. 27(6). e12932–e12932. 6 indexed citations
2.
On, Avi, et al.. (2021). Recurrent Late-Onset Neonatal Group B Streptococcal Disease Transmitted Through Breast Milk.. PubMed. 23(4). 256–257. 1 indexed citations
3.
Boneh, Rotem Sigall, Johan Van Limbergen, Eytan Wine, et al.. (2020). Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn’s Disease. Clinical Gastroenterology and Hepatology. 19(4). 752–759. 64 indexed citations
4.
Levine, Arie, Eytan Wine, Amit Assa, et al.. (2019). Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 157(2). 440–450.e8. 417 indexed citations breakdown →
5.
On, Avi, et al.. (2018). Characteristics of Antibiotic Resistance of Helicobacter pylori Among Adult Arab and Jewish Populations in Northern Israel. Microbial Drug Resistance. 25(1). 103–107. 4 indexed citations
6.
On, Avi, et al.. (2017). [COMPARISON OF CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF ARAB AND JEWISH CHILDREN LIVING IN THE GALILEE WHO HAVE SUFFERED FROM AN INTESTINAL INFECTION CAUSED BY CAMPYLOBACTER].. PubMed. 156(10). 631–634. 1 indexed citations
7.
On, Avi, et al.. (2017). [CONGENITAL ILEAL STENOSIS: LATE CLINICAL MANIFESTATIONS OF EARLY PRENATAL SUSPICION].. PubMed. 156(10). 619–622.
8.
Levine, Arie, Baruch Yerushalmi, Michal Kori, et al.. (2017). Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study. Journal of Crohn s and Colitis. 11(8). 970–974. 8 indexed citations
9.
Pastukh, Nina, et al.. (2017). Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel. Journal of Global Antimicrobial Resistance. 12. 175–178. 13 indexed citations
11.
Turner, Dan, Baruch Yerushalmi, Michal Kori, et al.. (2016). Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial. Journal of Crohn s and Colitis. 11(5). jjw180–jjw180. 14 indexed citations
12.
Tener, Dafna, et al.. (2016). Seriously clowning: Medical clowning interaction with children undergoing invasive examinations in hospitals. Social Work in Health Care. 55(4). 296–313. 13 indexed citations
13.
Peretz, Avi, et al.. (2015). Susceptibility of Helicobacter pylori to Levofloxacin and Rifampicin in Israel. Microbial Drug Resistance. 21(4). 448–451. 8 indexed citations
14.
Peretz, Avi, et al.. (2015). An efficiency comparison between three invasive methods for the diagnosis of Helicobacter pylori infections: Culture from stomach biopsy, rapid urease test (CUTest(®)), and histologic examination of gastric biopsy.. PubMed. 45(2). 148–51. 7 indexed citations
15.
Peretz, Avi, et al.. (2015). Improvement and optimization of the classical gastric biopsy culture technique for Helicobacter pylori diagnosis using trypsin. Journal of Medical Microbiology. 64(6). 642–645. 6 indexed citations
16.
Peretz, Avi, et al.. (2014). Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults. The Journal of Antibiotics. 67(8). 555–557. 28 indexed citations
17.
Levine, Arie, Michal Kori, Gabriel Dinari, et al.. (2009). Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohnʼs disease: A randomized placebo-controlled trial. Inflammatory Bowel Diseases. 15(7). 1055–1061. 25 indexed citations
18.
Levine, Arie, Zvi Weizman, Efrat Broide, et al.. (2003). A Comparison of Budesonide and Prednisone for the Treatment of Active Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 36(2). 248–252. 58 indexed citations
19.
Levine, Arie, Zvi Weizman, Efrat Broide, et al.. (2003). A Comparison of Budesonide and Prednisone for the Treatment of Active Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 36(2). 248–252. 5 indexed citations
20.
Lichtig, Chaim, et al.. (1991). Childhood Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Continuous Spectrum of Disease?. American Journal of Nephrology. 11(4). 325–331. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026